2014-04-03 11:17:35 - Mostafa Ronaghi, Illumina to Keynote at Next Generation Seq Meeting on June 19-20, 2014 in San Diego
Mostafa Ronaghi, Senior Vice President and Chief Technology Officer at Illumina to give a keynote presentation at the 4th Annual Next Generation Sequencing Conference on June 19-20, 2014 in San Diego, CA by GTC.
Dr. Mostafa Ronaghi, Ph.D., joined Illumina in August 2008 and is responsible for leading internal research programs and evaluating new technologies for the Company. Dr. Ronaghi is an experienced entrepreneur and was involved in the start-up of four life sciences companies. In 2007, Mostafa co-founded Avantome, a privately-held sequencing company. Before this, he co-founded NextBio, a search engine for life science data. In 2001, Mostafa co-founded ParAllele Bioscience, which was eventually acquired by Affymetrix, Inc., and was involved in the development and commercialization of highly multiplexed technology
for genetic testing. In 1997, he co-founded Pyrosequencing AB, which was renamed to Biotage in 2003, and led the company to a successful initial public offering in June 2000 on the Stockholm Stock Exchange. Mostafa was a principal investigator at Stanford University from 2002–2008 and focused on the development of novel tools for molecular diagnostic applications. He serves on the board of directors of Microchip Biotechnologies, NextBio, and Aurora Biofuels.
Mostafa earned his Ph.D. from the Royal Institute of Technology in Sweden. Mostafa holds more than 20 pending and issued patents and has written more than 50 peer-reviewed publications in journals and books.
GTC’s 4th Next Generation Sequencing Conference will provide a forum for leaders in the next generation sequencing field to present and discuss the current and future applications of the technology as well as share strategies, best practices and protocols on the usage of the tool. Attend this conference to network with fellow scientists and researchers and learn about sequencing technologies that are available, how they are being applied and what are the strategies for handling the data.
This conference is also part of the Nucleic Acid Summit , which consists of this conference and three other conferences:
1) Non-Coding RNAs and RNAi Research & Therapeutics
2) Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data
3) Nucleic Acid Research & Discovery
For more information, please visit www.gtcbio.com/